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Abstract
Background: Most pediatric adenovirus respiratory infections are mild and indistinguishable from other viral
causes. However, in a few children, the disease can be severe and result in substantial morbidity. We describe the
epidemiologic, clinical, radiologic features and outcome of adenovirus lower respiratory tract infections (LRTI) in
Aboriginal and Non-Aboriginal children in Manitoba, Canada during the years 1991 and 2005.
Methods: This was a retrospective study of 193 children who presented to the department of pediatrics at
Winnipeg Children’s Hospital, Manitoba, Canada with LRTI and had a positive respiratory culture for adenovirus.
Patients’ demographics, clinical and radiologic features and outcomes were collected. Adenovirus serotype
distributions and temporal associations were described. Approximate incidence comparisons (detection rates) of
adenovirus LRTI among Aboriginal and Non-Aboriginal children were estimated with 95% confidence intervals.
Results: Adenovirus infections occurred throughout the year with clusters in the fall and winter. Serotypes 1 to 3
were the predominant isolates (two thirds of the cases). The infection was more frequent among Canadian
Aboriginals, as illustrated in 2004, where its incidence in children 0-4 years old was 5.6 fold higher in Aboriginals
(13.51 vs. 2.39 per 10,000, p < 0.000). There were no significant differences in length of hospitalization and use of
ventilator assistance between the two groups (p > 0.185 and p > 0.624, respectively) nor across serotypes (p > 0.10
and p > 0.05, respectively). The disease primarily affected infants (median age, 9.5 months). Most children
presented with bronchiolitis or pneumonia, with multi-lobar consolidations on the chest x-ray. Chronic (residual)
changes were documented in 16 patients, with eight patients showing bronchiectasis on the chest computerized
tomography scan.
Conclusions: Adenovirus infection is associated with significant respiratory morbidities, especially in young infants.
The infection appears to be more frequent in Aboriginal children. These results justify a careful follow-up for
children with adenovirus LRTI.
Background
Adenoviruses play a significant role in pediatric infec-
tions, accounting for 2-5% of the overall respiratory ill-
nesses and 4-10% of the pneumonias [1]. Fifty-six
adenovirus serotypes are known so far and are classified
into 7 species (species A to G) on the basis of serology,
whole genome sequencing and phylogenomics [2-6].
The subspecies B1 includes serotypes 3, 7 and 21,
which are responsible for most of the adenovirus lower
respiratory tract infection (LRTI) epidemics [7]. The
species C includes serotypes 1, 2, 5 and 6, and the spe-
cies E includes serotype 4. These serotypes are also
common causes of pediatric upper and lower respiratory
infections [8-14].
In otherwise healthy children, most adenovirus
respiratory infections are mild and indistinguishable
from other viral causes. However, specific serotypes,
such as serotypes 3, 7 and 14, have been implicated with
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reported among newborns and patients with underlying
medical conditions [18,19].
In a study of 41 patients with adenovirus bronchiolitis
in Manitoba between 1974 and 1978, Wenman et al.
depicted the natural history and emphasized the serious-
ness of adenovirus infections among young infants. Pre-
dilection of the disease in Canadian Aboriginal children
(32 of 41 patients) was demonstrated, with an increased
fatality rate in that group (5 of 41 patients). All Non-
Aboriginal children survived. The authors suggested
future studies to explore this issue [20].
This apparent susceptibility of Aboriginal children to
adenoviruses needs to be confirmed and investigated
further. Genetic, socio-economic and nutritional vari-
ables have been suggested [20,21]. Furthermore, it is
unclear whether these findings will persist decades later.
The primary aims of this study were to describe the epi-
demiologic, clinical, radiologic features and outcome of
adenovirus LRTI in Aboriginal and Non-Aboriginal chil-
dren in Manitoba, Canada during the years 1991-2005.
Methods
Patients and settings
The Aboriginal and Non-Aboriginal children live in dif-
ferent settings in Manitoba. In 2001, 34.7% of Manito-
ba’s Aboriginal people lived within the municipal
boundaries of the City of Winnipeg, while the remaining
lived on-reserve scattered throughout the province or in
other urban settings. Non-Aboriginal children live
mainly in urban areas [28].
Despite their wide geographical distribution, both
populations ultimately seek the same Children’s
Hospital.
Study design
This retrospective study involved children 0 to 4 years
of age who presented to the pediatric outpatient and
emergency departments at Winnipeg Children’s Hospital
(Manitoba, Canada) between February 1991 and Octo-
ber 2005 with LRTI and positive respiratory culture for
adenovirus.
The study sample was sourced from adenovirus cul-
ture positive specimens. Subsequently, a chart review
(emergency department, outpatient and inpatient
records) was done on those adenovirus positive culture
cases and those with a diagnosis of LRTI were selected
for analysis.
Recognition of pediatric LRTI was based on the phy-
sician diagnosis of pneumonia, bronchitis and bronch-
iolitis. (All medical codes in the Health Sciences
Center Historical Abstracting System, WinRecs that
contain the words “pneumonia”, “bronchitis” or
“bronchiolitis” were included.) Only the first
adenovirus respiratory isolate, during a single clinical
event, was included in the analysis. The studied cases
did not include readmissions. Participants’ demo-
graphic, clinical and radiologic findings were collected.
Clinical outcome data were assessed according to days
of hospitalization, use of mechanical ventilation, and
mortality. Aboriginal ethnicity was identified by the
demographic data. Approximate annual incidence
(detection rate) of adenovirus LRTI among Aboriginal
and Non-Aboriginal children was calculated from 1999
to 2005 as the ratio of the number of infected children
0-4 years old in the target year to the number of 0-4
year-old children in the corresponding ethnic group
living in Manitoba in 2001 (i.e., 20,725 Aboriginals and
50,305 Non-Aboriginals) [28]. The numbers of 0 to 4
year-old children in 2001 were used as the base values
in this calculation because 2001 is close to the median
year of the study period (1999 - 2005) and the lack of
data on the relevant population sizes in the other
study years.
The study was approved by Bannatyne Campus
Research Ethics Board at the University of Manitoba,
Winnipeg, Canada (H2006:166).
Specimens
Although testing for respiratory viruses was not a stan-
dard policy for all LRTI admissions during the study
period, this was a usual practice. All nasopharyngeal
aspirate specimens received at Cadham Provincial
Laboratory (CPL), during the study period had received
culture for adenovirus. Moreover, cultures for influenza
A and B, parainfluenza 1, 2, 3, and 4, respiratory syncy-
tial virus (RSV), respiratory enteroviruses and (on
request) rhinoviruses were also done for all specimens.
Rapid antigen detection for influenza A and RSV was
conducted during their respective seasons. Influenza B
rapid antigen testing was offered during any heavy B
seasons.
Nasopharyngeal aspirate specimens were collected in
virus transport media. During daytime, the samples were
immediately transported at 4°C with a cold pack to CPL,
which was adjacent to the Children’s Hospital. At nights
and weekends, the samples were stored at the microbiol-
ogy laboratory of the Children’s Hospital. Nevertheless,
the procedures of sample collection and transportation
were consistent throughout the study.
Specimens were processed as described [30]. Cultures
were observed for 3 to 4 weeks for cytopathic effects or
hemadsorption, and were further tested by indirect
immunofluorescence staining. The various kits used
throughout the study were conducted exactly according
to manufacturer directions. Therefore, the impact of
changes in laboratory techniques during this time is
expected to be negligible.
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common respiratory serotypes in children (types 1-7)
were identified by neutralization assays with type-speci-
fic reference antisera [14,31]. Other serotypes were not
tested.
Statistical analysis
T h ed a t aw e r ea n a l y z e du s i n gS P S S - P Cs o f t w a r ep a c k -
age, version 18.0 (IBM Corporation, NY, USA). Preva-
lence rate was calculated with 95% CI. Mann Whitney
test was used to compare the median values of quanti-
tative responses across groups and chi square was used
for categorical variables. Simple logistic regression ana-
lysis was used to compare the use of mechanical venti-
lation across serotypes. Centered moving averages of
the monthly serotype records were used to study sea-
sonality of the incidence of serotypes. The F-test of
linear trend in the simple linear regression was used to
test the presence of a linear trend in the monthly
records. A multiplicative time series model was
assumed to identify the annual and monthly variations
of the series of monthly incidences of all serotypes. For
all these tests, statistical significance was defined for p
< 0.05. The individual control chart (I chart) was used
to detect whether the process of yearly incidences was
stable.
Results
Epidemiology
One hundred ninety three children were identified with
LRTI and positive respiratory culture for adenovirus
(Table 1). The patients were predominantly infants
(mean age ± SD = 11.1 ± 8.1 months). One hundred
and twelve (58%) affected children were Canadian
Aboriginals.
The incidence of adenovirus infection in Aboriginals
appeared to be higher than in Non-Aboriginals. The
approximate incidence rate of adenovirus infection in
children of 0 to 4 years per 10,000 per year, (see Meth-
ods) between 1999 and 2005 ranged from 0.097 to 1.351
for Aboriginals and 0.020 to 0.358 for Non-Aboriginals.
For example, in 2004, the incidence among Aboriginals
was about 5.6 fold higher than in Non-Aboriginals
(1.351 vs. 0.239, p < 0.00).
Figure 1 shows the yearly variation in the incidence of
adenovirus infection in Aboriginal and Non-Aboriginal
children. It displays the average incidence after remov-
ing the season’s effect (here, season = month). Higher
incidences were noted in 2001 and 2004.
The series of monthly records of the incidence of ser-
otypes appeared to be stationary, i.e., the incidence was
relatively stable over the studied years (test of linear
trend had p = 0.751 for Aboriginals and p = 0.382 for
Non-Aboriginals).
Of note, from 1999 to 2005, there were 177 adeno-
virus isolates, representing 3.0% of total LRTI and 15.1%
of confirmed viral LRTI.
Virology
During the study period, seven adenovirus serotypes were
isolated from the nasopharyngeal aspirates (Table 1). Sero-
types 1-3 were the most common, accounting for about
two-thirds of the isolates. Ten isolates were un-typed.
Table 1 Epidemiologic, clinical and virologic
characteristics of 193 Manitoban children with
Adenovirus LRTI
Characteristics n (%)
Female 68 (35%)
Age (mo) 11.1 ± 8.1
Canadian Aboriginal 112 (58%)
History of prematurity (< 37 weeks gestation) 23 (12%)
Hospitalization 128 (66%)
Length of hospitalization (days)
# 5 (1-189)
Clinical findings
fever 128 (67%)
hypoxia 86 (46%)
rales 86 (45%)
wheezing 85 (45%)
conjunctivitis 13 (7%)
otitis media 19 (10%)
vomiting 39 (20%)
diarrhea 38 (20%)
Serotypes
¶
1 40 (22%)
2 53 (29%)
3 37 (20%)
4 6 (3%)
5 18 (10%)
6 5 (3%)
7 24 (13%)
Associated isolates
RSV 11 (6%)
Parainfluenza 6 (3%)
Influenza A 1 (< 1%)
CMV 1 (< 1%)
K. pneumoniae 2 (< 1%)
B. pertussis 1 (< 1%)
Managements
antibiotics 139 (72%)
salbutamol 127 (66%)
oxygen 88 (46%)
steroids 60 (31%)
mechanical ventilation 21 (11%)
Bronchiectasis 8 (4%)
Values are mean ± SD; otherwise, number (percent) of patients.
# Median is reported with (range).
¶ Ten isolates were un-typed.
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tions peaked in the fall and winter (Figure 2), especially ser-
otypes 1-3, 5 and 7 (data not shown). Two outbreaks
(notable rises in the incidence of infections) occurred (Fig-
ure 3A-B), one in 2001 (predominantly serotype 3) and
one in 2004 (predominantly serotypes 2 and 1).
Clinical data at presentation
Two-thirds of the children were hospitalized (median =
5 days, range = 1.0 to 189 days). Most of them had
pneumonia (46%) or bronchiolitis (38%). Wheezing and
hypoxia were documented in about half of the patients.
Extra-pulmonary manifestations included vomiting
(20%), diarrhea (20%) and conjunctivitis (7%).
Many patients received antibiotics (72%), bronchodila-
tors (66%), oxygen (46%) and steroids (31%). Mechanical
ventilation was used in 11%.
Two-thirds (141 of 193) of the patients had lobar con-
solidation on the chest x-ray. All lobes were equally
affected and the involvement was multi-lobar in 56
(28%) and bilateral in 33 (17%) patients. Residual
changes on follow-up evaluations were present in 16
patients, including bronchiectasis in 8 children.
Co-infections with other respiratory viruses were
found in 19 (10%) patients (11 RSV, 6 parainfluenza, 1
influenza A and 1 CMV). The co-infection did not
adversely affect the length of hospitalization (p =0 . 0 9 6 )
or the incidence of bronchiectasis (p=0.797).
Figure 1 Annual means of seasonally-adjusted series of monthly records of incidence of all serotypes among 0 to 4 year-old
Aboriginal and Non-Aboriginal children. The annual average of seasonally-adjusted incidence, that is, the incidence in each month was
divided by the season’s factor (months with high incidence had a factor > 1, while months with low incidence had a factor < 1) then the
average for the 12 months of each year was computed.
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All patients were discharged home and there were no
deaths. There were no significant differences between
Aboriginal and Non-Aboriginal children in the length of
hospitalization (p = 0.185) or the use of mechanical ven-
tilation (of 21 patients who had ventilation, 11 were
Aboriginal and 10 were Non-Aboriginal, p=0.624).
Moreover, the length of hospitalization and the use of
ventilation did not differ across serotypes (p = 0.612 and
p = 0.072, respectively).
Only 27 (14%) of the 193 children had documented
long-term outpatient follow-up and 11 (6%) had
bronchoscopy. All children had chest x-ray and 10 had
chest computerized tomography (CT) scan.
Bronchiectasis (single or multiple lobes) was diagnosed
on the chest CT scan in eight patients (4%); three had
serotype 1, two had serotype 3, one had each of the ser-
otypes 2, 7 and 5 (Table 2). There was no statistically
significant association between bronchiectasis and sero-
types (p = 0.822). Bronchiectasis distributed equally
among Canadian Aboriginal and Non-Aboriginal chil-
dren (p = 0.638). The prevalence of bronchiectasis
among both ethnic groups was estimated, with 95% con-
fidence, between 0.02 and 0.08.
Discussion
Adenovirus LRTI occurred endemically throughout the
year, with clusters in the fall and winter. A seasonal
peak in November-December was clearly noticeable
(Figure 2). This result is consistent with a recent report
from Western Australian Aboriginal and Non-Aborigi-
nal children, showing a clear seasonality for adenovirus
identifications [22]. Thus, adenoviruses should be con-
sidered all year long and surveillance programs should
be in place to monitor peaks in infection rates.
In the studied population, serotypes 1-3 were the most
commonly identified adenovirus serotypes (Table 1).
This finding is consistent with reports from other geo-
graphic regions, including Korea, Texas and Toronto.
[23-25]. However, 10 isolates were un-typed, possibly
due to failure of the neutralization assay. Un-typed iso-
lates could be non 1-7 serotypes, such as 14 or 21,
which potentially circulate around that time period.
Molecular methods for typing adenoviruses, such as
restriction fragment length polymorphism (RFLP), PCR-
based assays, microarray-based methods and phyloge-
netic analysis have now been established and may over-
come the practical issues with the traditional
neutralization assay. They are becoming more important
for epidemiological surveillance, outbreak investigation,
and detection of new strains as well as understanding
the pathogenesis of adenovirus infection [26,27].
The infection rate was strikingly high among Canadian
Aboriginals, considering their proportion in the studied
population. While the total population of Manitoba has
been relatively stable over the last 20 years, the
Figure 2 The monthly averages of a centered-moving average (of span 3) of monthly records of all serotypes among 0 to 4 year-old
children between 1999 and 2005.
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higher birth rate, combined with an Aboriginal mortality
rate that is much lower than prior to 1981. The Aborigi-
nals constituted 8.7% of the Manitoba population in
1986, 10.6% in 1991, 11.7% in 1996, 13.6% in 2001, and
15.5% in 2006. The percentage of Aboriginal children in
2001 was 25% of those 0-4 years of age and 28% in
2006 of those 0-4 years of age [28]. Earlier Manitoban
and New Zealand experiences showed an increased
occurrence of adenoviruses in Aboriginal children
Figure 3 Annual records (1999 to 2005) of all serotypes (Panel A) and of each serotype (Panel B) for 0 to 4 year-old children.
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persistence since at least 1969. However, the outcome
appears to be similar between the two groups.
Seventeen (15.2%) of 112 Aboriginal patients had
house-hold smoking; while 10 (12.3%) of 81 Non-Abori-
ginal patients had house-hold smoking (p =0 . 5 7 6 ) .A s
previously suggested, factors that could contribute to a
high predilection of adenovirus infection in Aboriginal
children include socioeconomic, crowding and nutri-
tional conditions [20,21]. Further studies are much
needed to explore these risk variables.
The high prevalence (73%) of consolidation on chest
x-ray may suggest bacterial co-infection. The possibility
of viral/bacterial co-infection as a cause of the x-ray
findings is thus realistic, especially since 72% of the
patients received antibiotics (Table 1). Furthermore, the
x-ray findings reported here were merely based on the
radiologist report. Compared to pediatric pulmonologist
readings, the use of radiologic criteria for diagnosing
pneumonia could be suboptimal. Bronchiectasis was
f o u n di n8p a t i e n t s :o fw h o m2h a dn op r i o rl u n gd i s -
ease, 2 had bronchiolitis obliterans with organizing
pneumonia (BOOP), 3 had asthma and 1 had unknown
past-medical history (Table 2). It is, therefore, possible
that a prior lung disease could have contributed to the
development of bronchiectasis. In a 10-year follow up
study, Simila et al. found 12 of 27 patients with type 7
adenovirus infections developed bronchiectasis [29].
Since only 14% of children had documented long-term
follow-up, the observed incidence of chronic lung
changes is very likely underestimated. These findings,
however, highlight the importance of a close clinical and
radiologic follow-up of children with adenovirus LRTI.
Further prospective studies are required to investigate
which risk factors are associated with these long-term
changes.
The findings here need to be interpreted with some
caution. First, adenovirus testing was performed in a
hospital setting, which might overestimate the serious
nature of adenovirus infections. Second, like most retro-
spective epidemiological studies, data are often incom-
plete and analyses can be subject to bias.
Conclusions
The epidemiologic, clinical, radiologic features and out-
come of adenovirus LRTI in Aboriginal and Non-Abori-
ginal children in Manitoba, Canada are discussed.
Significant respiratory morbidities were associated with
adenovirus infections, especially in young infants. The
infection was more frequent in Aboriginal children. Sig-
nificant chronic lung changes may occur following ade-
novirus infection, emphasizing the need for long-term
follow-up.
Note
Communicated by Alharbi et al
Acknowledgements
We thank Karen Olekson from the Health Sciences Centre, Winnipeg,
Manitoba who helped with data collection. The contribution of Hassib
Table 2 Characteristics of the eight patients with bronchiectasis
Age
(mo)
Gender Ethnicity Adenovirus
Serotype
Admission Location Days of
Hospitalization
House-
hold
Smoking
Management Associated
Diagnoses
11 male Canadian
Aboriginal
3 July 2001 Rt middle
lobe
112 Yes ventilation, oxygen,
salbutamol, steroids,
antibiotics
BOOP
5 female Canadian
Non-
Aboriginal
2 Nov 2000 Lt lower lobe 12 No oxygen, salbutamol,
steroids, antibiotics
Asthma
11 male Canadian
Aboriginal
3 Dec 2002 Rt middle and
lower lobes
8 No oxygen, salbutamol,
steroids, antibiotics
Asthma
16 male Canadian
Aboriginal
7 June 1999 Lt lower lobe 7 No oxygen, salbutamol,
steroids, antibiotics
No follow
up
20 male Canadian
Non-
Aboriginal
1 Dec 2000 Rt and Lt
lower lobes
3 No salbutamol,
antibiotics
None
3 female Canadian
Non-
Aboriginal
5 March
2004
Rt and Lt
upper lobes
Lt lower lobe
189 Yes ventilation, oxygen,
salbutamol, steroids,
antibiotics
Asthma
16 male Canadian
Non-
Aboriginal
1 Nov 2000 Rt upper and
lower lobes
8 No oxygen, salbutamol,
steroids, antibiotics
None
8 male Canadian
Aboriginal
1 April 1999 Rt upper and
middle lobes
25 No ventilation, oxygen,
salbutamol, steroids
BOOP
BOOP bronchiolitis obliterans with organizing pneumonia.
Alharbi et al. BMC Infectious Diseases 2012, 12:55
http://www.biomedcentral.com/1471-2334/12/55
Page 7 of 8Narchi, professor of pediatrics at UAE University, in revising the manuscript is
greatly appreciated.
Author details
1Umm Al-Qura University, Makkah, P.O. Box 6707, Saudi Arabia.
2Department
of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB R3T
2N2, Canada.
3Cadham Provincial Laboratory, Winnipeg, MB R3E 3J7, Canada.
4Department of Statistics, United Arab Emirates University, Al Ain, P.O. Box
17666, United Arab Emirates.
5Department of Pediatrics, United Arab
Emirates University, Al Ain, P.O. Box 17666, United Arab Emirates.
Authors’ contributions
SA, PVC and RCA participated in study design and data acquisition. TZ
performed statistical analysis. SF participated in data acquisition. AKS
participated in manuscript writing. ARA performed study design, data
acquisition, data analysis and manuscript writing. All authors read and
approved the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 7 September 2011 Accepted: 13 March 2012
Published: 13 March 2012
References
1. Cherry JD: Textbook of pediatric infectious diseases. 4 edition. Philadelphia:
WB Saunders; 1988.
2. Robinson CM, Singh G, Henquell C, Walsh MP, Peigue-Lafeuille H, Seto D,
Jones MS, Dyer DW, Chodosh J: Computational analysis and identification
of an emergent human adenovirus pathogen implicated in a respiratory
fatality. Virology 2010, 409(2):141-147.
3. Jones MS, Harrach B, Ganac RD, Gozum MM, Dela Cruz WP, Riedel B, Pan C,
Delwart EL, Schnurr DP: New adenovirus species found in a patient
presenting with gastroenteritis. J Virol 2007, 81(11):5978-5984.
4. Kaneko H, Iida T, Ishiko H, Ohguchi T, Ariga T, Tagawa Y, Aoki K, Ohno S,
Suzutani T: Analysis of the complete genome sequence of epidemic
keratoconjunctivitis-related human adenovirus type 8, 19, 37 and a
novel serotype. J Gen Virol 2009, 90(Pt 6):1471-1476.
5. Walsh MP, Chintakuntlawar A, Robinson CM, Madisch I, Harrach B,
Hudson NR, Schnurr D, Heim A, Chodosh J, Seto D, et al: Evidence of
molecular evolution driven by recombination events influencing tropism
in a novel human adenovirus that causes epidemic keratoconjunctivitis.
PLoS One 2009, 4(6):e5635.
6. Walsh MP, Seto J, Jones MS, Chodosh J, Xu W, Seto D: Computational
analysis identifies human adenovirus type 55 as a re-emergent acute
respiratory disease pathogen. J Clin Microbiol 2010, 48(3):991-993.
7. Moro MR, Bonville CA, Suryadevara M, Cummings E, Faddoul D, Kobayaa H,
Branigan PJ, Domachowske JB: Clinical features, adenovirus types, and
local production of inflammatory mediators in adenovirus infections.
Pediatr Infect Dis J 2009, 28(5):376-380.
8. Rowe WP, Huebner RJ, Gilmore LK, Parrott RH, Ward TG: Isolation of a
cytopathogenic agent from human adenoids undergoing spontaneous
degeneration in tissue culture. Proc Soc Exp Biol Med 1953, 84(3):570-573.
9. Kidd AH, Jonsson M, Garwicz D, Kajon AE, Wermenbol AG, Verweij MW, De
Jong JC: Rapid subgenus identification of human adenovirus isolates by
a general PCR. J Clin Microbiol 1996, 34(3):622-627.
10. Singh-Naz N, Brown M, Ganeshananthan M: Nosocomial adenovirus
infection: molecular epidemiology of an outbreak. Pediatr Infect Dis J
1993, 12(11):922-925.
11. Kajon AE, Mistchenko AS, Videla C, Hortal M, Wadell G, Avendano LF:
Molecular epidemiology of adenovirus acute lower respiratory infections
of children in the south cone of South America (1991-1994). J Med Virol
1996, 48(2):151-156.
12. Erdman DD, Xu W, Gerber SI, Gray GC, Schnurr D, Kajon AE, Anderson LJ:
Molecular epidemiology of adenovirus type 7 in the United States,
1966-2000. Emerg Infect Dis 2002, 8(3):269-277.
13. Schmitz H, Wigand R, Heinrich W: Worldwide epidemiology of human
adenovirus infections. Am J Epidemiol 1983, 117(4):455-466.
14. Hierholzer JC, Stone YO, Broderson JR: Antigenic relationships among the
47 human adenoviruses determined in reference horse antisera. Arch
Virol 1991, 121(1-4):179-197.
15. Kim YJ, Hong JY, Lee HJ, Shin SH, Kim YK, Inada T, Hashido M, Piedra PA:
Genome type analysis of adenovirus types 3 and 7 isolated during
successive outbreaks of lower respiratory tract infections in children. J
Clin Microbiol 2003, 41(10):4594-4599.
16. Lewis PF, Schmidt MA, Lu X, Erdman DD, Campbell M, Thomas A,
Cieslak PR, Grenz LD, Tsaknardis L, Gleaves C, et al: A community-based
outbreak of severe respiratory illness caused by human adenovirus
serotype 14. J Infect Dis 2009, 199(10):1427-1434.
17. O’Flanagan D, O’Donnell J, Domegan L, Fitzpatrick F, Connell J, Coughlan S,
De Gascun C, Carr MJ: First reported cases of human adenovirus serotype
14p1 infection, Ireland, October 2009 to July 2010. Euro Surveill 2011,
16(8), pii = 19801.
18. Ghanaiem H, Averbuch D, Koplewitz BZ, Yatsiv I, Braun J, Dehtyar N,
Wolf DG, Mandelboim M, Engelhard D: An outbreak of adenovirus type 7
in a residential facility for severely disabled children. Pediatr Infect Dis J
2011, 30(11):948-952.
19. Kelley CJ: A fatal case of neonatal adenovirus infection. Neonatal Netw
2010, 29(5):297-305.
20. Wenman WM, Pagtakhan RD, Reed MH, Chernick V, Albritton W:
Adenovirus bronchiolitis in Manitoba: epidemiologic, clinical, and
radiologic features. Chest 1982, 81(5):605-609.
21. Lang WR, Howden CW, Laws J, Burton JF: Bronchopneumonia with serious
sequelae in children with evidence of adenovirus type 21 infection. Br
Med J 1969, 1(5636):73-79.
22. Moore HC, de Klerk N, Richmond P, Keil AD, Lindsay K, Plant A, Lehmann D:
Seasonality of respiratory viral identification varies with age and
Aboriginality in metropolitan Western Australia. Pediatr Infect Dis J 2009,
28(7):598-603.
23. Hong JY, Lee HJ, Piedra PA, Choi EH, Park KH, Koh YY, Kim WS: Lower
respiratory tract infections due to adenovirus in hospitalized Korean
children: epidemiology, clinical features, and prognosis. Clin Infect Dis
2001, 32(10):1423-1429.
24. Laham FR, Jewell AM, Schoonover SL, Demmler GJ, Piedra PA: The search
for adenovirus 14 in children in Houston, Texas. Pediatr Infect Dis J 2008,
27(7):653-654.
25. Yeung R, Eshaghi A, Lombos E, Blair J, Mazzulli T, Burton L, Drews SJ:
Characterization of culture-positive adenovirus serotypes from
respiratory specimens in Toronto, Ontario, Canada: September 2007-
June 2008. Virol J 2009, 6:11.
26. Allard A, Albinsson B, Wadell G: Rapid typing of human adenoviruses by a
general PCR combined with restriction endonuclease analysis. J Clin
Microbiol 2001, 39(2):498-505.
27. Rebelo-de-Andrade H, Pereira C, Giria M, Prudencio E, Brito MJ, Cale E,
Taveira N: Outbreak of acute respiratory infection among infants in
Lisbon, Portugal, caused by human adenovirus serotype 3 and a new 7/
3 recombinant strain. J Clin Microbiol 2010, 48(4):1391-1396.
28. Aboriginal People in Manitoba. [http://www.gov.mb.ca/ana/pdf/apm2006.
pdf], (10 December 2011)..
29. Simila S, Linna O, Lanning P, Heikkinen E, Ala-Houhala M: Chronic lung
damage caused by adenovirus type 7: a ten-year follow-up study. Chest
1981, 80(2):127-131.
30. Yun BY, Kim MR, Park JY, Choi EH, Lee HJ, Yun CK: Viral etiology and
epidemiology of acute lower respiratory tract infections in Korean
children. Pediatr Infect Dis J 1995, 14(12):1054-1059.
31. Hierholzer JC, Gamble WC, Dowdle WR: Reference equine antisera to 33
human adenovirus types: homologous and heterologous titers. J Clin
Microbiol 1975, 1(1):65-74.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/12/55/prepub
doi:10.1186/1471-2334-12-55
Cite this article as: Alharbi et al.: Epidemiology of severe pediatric
adenovirus lower respiratory tract infections in Manitoba, Canada, 1991-
2005. BMC Infectious Diseases 2012 12:55.
Alharbi et al. BMC Infectious Diseases 2012, 12:55
http://www.biomedcentral.com/1471-2334/12/55
Page 8 of 8